Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Insulin Therapy for Post-transplant Steroid-Induced Hyperglycemia
NCT01648218Phase 4Terminated
- Sponsor
- Vancouver General Hospital
- Start
- Aug 2012
- Primary completion
- Apr 2013
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of insulin glargine, insulin aspart, human insulin in glucocorticoid-induced diabetes mellitus (GIDM), sponsored by Vancouver General Hospital. Started Aug 2012; status: terminated.
02
Drugs
insulin glargineinsulin asparthuman insulin
03
Conditions
glucocorticoid-induced diabetes mellitus (GIDM)
Beyond the preview
Go deeper on NCT01648218.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01648218.